HUF 2-70 Depression and antidepressant drugs Flashcards

1
Q

Depression

A
  • Major depression: genetically predisposed
  • Reactive/adjustment disorder (life events)
  • Postpartum depression
  • Seasonal affective disorder
  • Comorbidity with anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Different types of affective / mood disorders

A
  • Major depressive disorder: recurrent depressive episodes
  • Bipolar affective disorder: mania/hypomania and depression
  • Anxiety disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Brain systems implicated in mood disorders

A
  • Changes in connectivity between limbic system and prefrontal cortex
    1. 5-HT system: raphe nu.
    2. NA: locus coeruleus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Monoamine theory of depression

A

Depression is caused by functional deficit of monoamine transmitters (NA, 5-HT) at certain sites of brain

Supportive evidence:

  • Antidepressant treatments
  • Depletion of monoamines by reserpine causes depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

5-HT and NA neurons

A

NA neurons:
- α2 autoreceptor at dendrites and axon terminals
=> ↓ NA from presynaptic neuron when activated

5-HT neurons:

  • α1 receptor at dendrites
  • α2 heteroreceptor at axon terminals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment principle based on monoamine theory of depression

A

SERT (serotonin transporter)
NET (norepinephrine transporter)
- Functioning: ↓ local conc. of released NT
- Blocked: transmission enhanced

α2 adrenoceptor
5HT-1A/B receptor
- Autoreceptors at presynaptic sides
- Activated: amount of NT ↓ per episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of antidepressants

A
  1. MAOI (monoamine oxidase inhibitor)
  2. MARI (monoamine reuptake inhibitors)
    - Classical tricyclic antidepressants (TCA)
    - Selective serotonin reuptake inhibitors (SSRI)
    - Selective noradrenaline reuptake inhibitors (NRI)
    - Serotonin-NA reuptake inhibitors (SNRI)
  3. Atypical antidepressants (monoamine receptor antagonists)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MAOI

A

MAO-A: metabolise NA, AD 5-HT, DA, tyramine
MaO-B: DA, tyramine

Moclobemide

  • Selective reversible inhibitor for MAO-A
  • Less likely to produce “cheese rxn”
  • Side effects: nausea, insomnia, agitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tricyclic antidepressants

A

Each drug shows diff. degree of inhibition on 5-HT/NA reuptake
e.g. Amitriptyline (prodrug) -> Nortriptyline
Imipramine (prodrug) -> Desipramine

Undesirable effects:

  • inhibit α1, M, H1
  • Sedation, postural hypotension, seizures, sexual dysfunction, cardiac arrhythmia (fatal if overdose)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SSRI, NRI, SNRI

A

Fluoxetine (Prozac), Citalopram, Paroxetine, Sertraline

  • Similar efficacy as TCA; fewer side effects, relative safer when overdosed
  • Side effect: agitation, insomnia, sexual dysfunction
  • DDI with non-selective MAOI and SSRI overdose
    => Serotonin symdrome

NRI: Bupropion => inhibit NA reuptake

SNRI: Venlafaxine => inhibit 5-HT and NA reuptake
- Less unlikely to cause undesirable effects than SSRIs during drug withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Time lag in clinical effectiveness of antidepressants

A

↑ NT
=> ↑ stimulation of inhibitory autoreceptors (soma, dendrites in raphe nu.)
=> ↑ inhibition of NT synthesis (undesirable effects)
∴ Cancels out beneficial effect of inhibiting reuptake
=> Desensitisation of presynaptic autoreceptors
=> ↓ inhibition of NT synthesis
=> ↑ postsynaptic receptor activity (therapeutic response)

  • Gradually increase dose of SSRI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DDI of SSRI and TCA

A
  • SSRI: CYP2D6 inhibitors
  • TCA: metabolised by CYP2D6
    ∴ When used together
    => DDI: ↑↑↑ 5-HT
    => Serotonin syndrome: agitation, hyperthermia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atypical antidepressants: monoamine receptor antagonist

A
  • Non-selective; inhibit α, 5HT-2 receptors
  • Weak effects on monoamine uptake
  1. NA control of 5HT release
    - 5HT release under regulation of excitatory action of NA on α1R
    - Inhibitory action on α2R
    - Mirtazapine, Mianserin
    => Antagonise α2 autoreceptor
    => ↑ 5HT release
    - Side effects: seizure, type 1 hypersensitivity
  2. 5HT-2AR
    - Higher expression of 5HT-2AR in postmortem brains of teenage suicide victims
    - Trazodone
    => Antagonise postsynaptic 5HT-2AR
    => ↑ DA and NA activity in frontal cortex]
    - Side effects: sedation, cardiac arrhythmia (also blocks M, H1 and α1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neurogenesis and depression

A
Adult hippocampal neurogenesis
- Neural stem cells
=> Transiently-amplifying progenitors
=> Immature neurons
=> Fully mature dentate gyrus GC neurons (4-6 weeks)

Reduced neurogenesis in depression
- Antidepressant require adult neurogenesis to improve mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neurotrophic hypothesis of depression

A
  • ↓ expression of brain-derived neurotrophic factor (BDNF) has adverse effects on neuronal plasticity
    => ↓ neuronal networks
    ↓ neuronal circuitry
    Hippocampal atrophy

Successful long-term antidepressant treatment associated with:

  • ↑ BDNF expression
  • Restoration of hippocampal function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug treatments for bipolar disorder

A
  1. Anti-epileptic drugs
    - Valproate, Carbamazepine
    - Mania exhibits episodic patterns involving neural over-activity
    - Calm down CNS neurons
  2. Lithium
  3. Atypical antipsychotics
    - Olanzapine, Aripiprazole
17
Q

Use of lithium in bipolar disorder

A
  • Acute mania
  • Prophylaxis of recurrent manic and depressive episodes (mood stabilisation)

Possible mechanisms of action:
1. Regulate genes that control GLU / 5HT production
2. Substitute for Na+ / Block K+ channels
=> Electrochemical gradients
3. Inhibit glycogen synthase kinase (GSK-3β)
∵ Increased GSK-3β activity associated with apoptosis and ↓ neurogenesis in CNS
=> Regulation transcription and expression of factors
- Neuroprotective, neurotrophic
- Anti-inflammatory, neurogenic, angiogenic
- Mood-stabilising, antidepressant-like anxiolytic
=> Neuroprotective effect

18
Q

Undesirable effects and DDI of lithium

A

Undesirable effects:

  • Acute lithium toxicity: confusion, convulsions, death (narrow therapeutic window)
  • Renal: nephrogenic DI
  • Hypothyroidism
  • Weight gain

DDI:

  • Renal toxicity when taken with loop diuretics or NSAIDs
  • Neurotoxicity when taken with Haloperidol, Phenothiazines (typical antipsychotics), Carbamazepine (anticonvulsant)